Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
219.29B
Market cap219.29B
Price-Earnings ratio
12.07
Price-Earnings ratio12.07
Dividend yield
2.39%
Dividend yield2.39%
Average volume
8.41M
Average volume8.41M
High today
$49.83
High today$49.83
Low today
$48.95
Low today$48.95
Open price
$49.32
Open price$49.32
Volume
5.78M
Volume5.78M
52 Week high
$71.80
52 Week high$71.80
52 Week low
$35.12
52 Week low$35.12

NVO News

Nasdaq 1h
Deceptive Advertising!" Claims Novo Nordisk in Explosive New GLP-1 Lawsuit Against Eli Lilly. Here's What That Means for Both Stocks.

Key Points Novo Nordisk has sued rival GLP-1 drugmaker Eli Lilly in federal court, alleging misleading advertising. Novo alleges that Lilly's ads compare a lo...

Deceptive Advertising!" Claims Novo Nordisk in Explosive New GLP-1 Lawsuit Against Eli Lilly. Here's What That Means for Both Stocks.
Cheddar 6h
Glp-1 Giants Take Their Battle to Court

Glp-1 Giants Take Their Battle to Court The rivalry between Novo Nordisk and Eli Lilly has escalated into a courtroom showdown, with Novo accusing its competit...

Glp-1 Giants Take Their Battle to Court
TipRanks 7h
Novo Nordisk’s AMAZE 13 Trial Adds Fresh Momentum to Its Obesity Pipeline

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...

Analyst ratings

57%

of 37 ratings
Buy
37.8%
Hold
56.8%
Sell
5.4%

More NVO News

Benzinga 9h
Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Weight Loss Drug Advertising

The lawsuit, filed in the U.S. District Court for the District of New Jersey, accuses the competitor of violating both state and federal false advertising and u...

Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Weight Loss Drug Advertising
TipRanks 9h
Eli Lilly Hit with Lawsuit by Rival Novo Nordisk Over Weight-Loss Drug Ads

Novo Nordisk (NVO) has filed a lawsuit against rival pharmaceutical company Eli Lilly (LLY), claiming that advertising campaigns for its weight-loss drugs are d...

Nasdaq 10h
Novo Nordisk's Dividend Story Is Changing -- Here's What Investors Are Missing

Key Points Novo Nordisk is one of the leading makers of GLP-1 weight-loss drugs. The stock has a well-above-market yield that is also well above its industry...

Novo Nordisk's Dividend Story Is Changing -- Here's What Investors Are Missing
The Wall Street Journal 11h
Novo Nordisk Files Deceptive Advertising Lawsuit Against Rival Eli Lilly

Novo Nordisk says it sent its rival a cease-and-desist letter in April. Mads Claus Rasmussen / AFP / Getty Images Novo Nordisk NOVO.B -1.68 %decrease; down poi...

Novo Nordisk Files Deceptive Advertising Lawsuit Against Rival Eli Lilly
TipRanks 11h
Novo Nordisk files lawsuit against ‘misleading’ GLP-1 ads from Eli Lilly

Novo Nordisk (NVO) announced that it has filed a lawsuit against Eli Lilly (LLY) in the United States District Court for the District of New Jersey for what it...

TipRanks 12h
Novo Nordisk suing Eli Lilly over weight-loss ads, Bloomberg reports

Novo Nordisk (NVO) said in U.S. federal court that it is suing Eli Lilly (LLY), claiming that its competitor’s advertising for its obesity shot Zepbound and dia...

CNBC 12h
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Key Points Novo Nordisk filed a lawsuit against Eli Lilly, alleging that its advertising campaigns for its blockbuster obesity and diabetes drugs are designed t...

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.